Completed peer reviews since:
June 5, 2020
About the Journal
About the Journal
Drug Target Insights (DTI) is an international, indexed, peer-reviewed, open access, online only journal, published once a year. It covers current developments in all areas of the field of clinical therapeutics, focusing on molecular drug targets which include disease-specific proteins, receptors, enzymes, and genes. The journal seeks to elucidate the impact of new therapeutic agents on patient acceptability, preference, satisfaction and quality of life and welcomes unsolicited article proposals. All articles are listed on PubMed and are freely available via PubMed Central.
DTI publishes new articles as soon as they are ready for publication (online first, as customary now for scientific journals) and then collected in an issue, to guarantee rapid publication times and a timely content availability for its indexing databases. DTI features two monothematic sections (Antimicrobial resistance (AMR) and Phytotherapeutics and natural products), each guided by an dedicated and experienced editor.
The antimicrobial section considering contributions dedicated tI the antimicrobial resistant infections caused by viruses, bacteria, fungi, protozoa, and helminths, mechanisms of antimicrobial resistance, identification and validation of novel molecular and cellular targets among pathogens and other relevant topics.
The phytotherapeutics and natural products section focuses on the health-promoting effects of natural products and phytotherapeutics as promising agents in the prevention and treatment of communicable and non-communicable diseases. Both preclinical (in vitro/in vivo) and clinical (in humans) studies are considered.